loadpatents
name:-0.2257080078125
name:-0.019044160842896
name:-0.019540071487427
Klein; Lawrence Patent Filings

Klein; Lawrence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klein; Lawrence.The latest application filed is for "systems and methods for customer data handling".

Company Profile
19.18.31
  • Klein; Lawrence - Cambridge MA
  • Klein; Lawrence - Saint Charles IL
  • Klein; Lawrence - Gladwyne PA
  • Klein; Lawrence - Long Beach NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
Grant 11,427,838 - Lundberg , et al. August 30, 2
2022-08-30
Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders
Grant 11,407,997 - Lundberg , et al. August 9, 2
2022-08-09
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,298,378 - Terrett , et al. April 12, 2
2022-04-12
Systems And Methods For Customer Data Handling
App 20220100892 - Safi; Farhat ;   et al.
2022-03-31
Materials And Methods For Treatment Of Spinocerebellar Ataxia Type 1 (sca1) And Other Spinocerebellar Ataxia Type 1 Protein (atxn1) Gene Related Conditions Or Disorders
App 20220047722 - LUNDBERG; Ante Sven ;   et al.
2022-02-17
Use Of Chimeric Antigen Receptor T Cells And Nk Cell Inhibitors For Treating Cancer
App 20220008473 - Terrett; Jonathan Alexander ;   et al.
2022-01-13
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,207,351 - Terrett , et al. December 28, 2
2021-12-28
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,202,802 - Terrett , et al. December 21, 2
2021-12-21
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,191,783 - Terrett , et al. December 7, 2
2021-12-07
Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders
Grant 11,174,469 - Lundberg , et al. November 16, 2
2021-11-16
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,166,985 - Terrett , et al. November 9, 2
2021-11-09
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,135,247 - Terrett , et al. October 5, 2
2021-10-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210252060 - Terrett; Jonathan Alexander ;   et al.
2021-08-19
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210236552 - Terrett; Jonathan Alexander ;   et al.
2021-08-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210236551 - TERRETT; Jonathan Alexander ;   et al.
2021-08-05
Methods and systems to quantify and index correlation risk in financial markets and risk management contracts thereon
Grant 11,080,789 - Guzman , et al. August 3, 2
2021-08-03
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,071,755 - Terrett , et al. July 27, 2
2021-07-27
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,013,767 - Terrett , et al. May 25, 2
2021-05-25
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210108174 - TERRETT; Jonathan Alexander ;   et al.
2021-04-15
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210085718 - Terrett; Jonathan Alexander ;   et al.
2021-03-25
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,881,689 - Terrett , et al. January 5, 2
2021-01-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20200405764 - Terrett; Jonathan Alexander ;   et al.
2020-12-31
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20200405761 - Terrett; Jonathan Alexander ;   et al.
2020-12-31
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,857,184 - Terrett , et al. December 8, 2
2020-12-08
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20200330518 - Terrett; Jonathan Alexander ;   et al.
2020-10-22
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,736,919 - Terrett , et al. A
2020-08-11
Compositions And Methods For Treatment Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9)-related Disorders
App 20200248168 - Kind Code
2020-08-06
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,729,725 - Terrett , et al.
2020-08-04
Materials And Methods For Treatment Of Spinocerebellar Ataxia Type 2 (sca2) And Other Spinocerebellar Ataxia Type 2 Protein (atx
App 20200216857 - LUNDBERG; Ante Sven ;   et al.
2020-07-09
Compositions And Methods For Gene Editing
App 20200157565 - Lundberg; Ante Sven ;   et al.
2020-05-21
Materials And Methods For Treatment Of Apolipoprotein C3 (apociii)-related Disorders
App 20200123570 - LUNDBERG; Ante Sven ;   et al.
2020-04-23
Materials And Methods For Treatment Of Merosin-deficient Cogenital Muscular Dystrophy (mdcmd) And Other Laminin, Alpha 2 (lama2)
App 20200095579 - LUNDBERG; Ante Sven ;   et al.
2020-03-26
Materials And Methods For Treatment Of Primary Hyperoxaluria Type 1 (ph1) And Other Alanine-glyoxylate Aminotransferase (agxt) G
App 20200080082 - Lundberg; Ante Sven ;   et al.
2020-03-12
Materials And Methods For Treatment Of Early Onset Parkinson's Disease (park1) And Other Synuclein, Alpha (snca) Gene Related Co
App 20200040061 - LUNDBERG; Ante Sven ;   et al.
2020-02-06
Materials And Methods For Treatment Of Dystrophic Epidermolysis Bullosa (deb) And Other Collagen Type Vii Alpha 1 Chain (col7a1)
App 20190365929 - LUNDBERG; Ante Sven ;   et al.
2019-12-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190365809 - Terrett; Jonathan Alexander ;   et al.
2019-12-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190365808 - Terrett; Jonathan Alexander ;   et al.
2019-12-05
Materials And Methods For Treatment Of Amyotrophic Lateral Sclerosis (als) And Other Related Disorders
App 20190330604 - LUNDBERG; Ante Sven ;   et al.
2019-10-31
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190314414 - TERRETT; Jonathan Alexander ;   et al.
2019-10-17
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190314413 - TERRETT; Jonathan Alexander ;   et al.
2019-10-17
Materials And Methods For Treatment Of Pain Related Disorders
App 20190224340 - Lundberg; Ante Sven ;   et al.
2019-07-25
Materials And Methods For Treatment Of Myotonic Dystrophy Type 1 (dm1) And Other Related Disorders
App 20190211362 - LUNDBERG; Ante Sven ;   et al.
2019-07-11
Compositions And Methods For Gene Editing
App 20190185849 - Lundberg; Ante Sven ;   et al.
2019-06-20
Materials And Methods For Treatment Of Friedreich Ataxia And Other Related Disorders
App 20190160186 - Lundberg; Ante Sven ;   et al.
2019-05-30
Materials And Methods For Treatment Of Pain Related Disorders
App 20190153477 - Lundberg; Ante Sven ;   et al.
2019-05-23
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20180325955 - Terrett; Jonathan Alexander ;   et al.
2018-11-15
Compositions And Methods For Gene Editing
App 20180127786 - Bouchon; Axel ;   et al.
2018-05-10
Automated loan approval system
Grant 8,326,748 - Klein December 4, 2
2012-12-04
Automated loan approval system
Grant 7,742,980 - Klein June 22, 2
2010-06-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed